The diagnosis of multiple sclerosis (MS) has significantly evolved over time, moving from a purely clinical approach to a more integrated model combining imaging and biological markers. Among these, cerebrospinal fluid (CSF) analysis has regained a central role. Recent advances, particularly the use of kappa free light chains (KFLC), are transforming diagnostic practices by offering a faster, more accessible, and reliable alternative to traditional methods.
Key Insights from the Lecture:
- CSF has long been essential in MS diagnosis
- Diagnostic criteria have evolved significantly
- MRI revolutionized MS detection
- CSF remains crucial in ambiguous cases
- Oligoclonal bands (OCBs) were the gold standard
- KFLC is emerging as a key biomarker
- KFLC can replace OCBs in many cases
- KFLC testing is faster and more accessible
- Diagnostic interpretation still requires context
- New criteria aim for earlier and more standardized diagnosis
“CSF in the new diagnostic criteria in multiple sclerosis”.
Please subscribe to watch.
About the speaker:
Rodica Bălaşa
Professor of Neurology at the Aristotle University of ThesProfessor of Neurology at the University of Medicine, Pharmacy, Sciences and Technology „George Emil Palade” of Targu Mures (UMFST), Romania.
Head of the Neurology 1 Clinic, Emergency Clinical County Hospital of Mures, Romania
Main field of research interest is the diagnosis and management of multiple sclerosis, cerebrospinal fluid biomarkers, and neuroimaging.
Active contributor to the development of diagnostic criteria and innovative approaches in MS care.
Media
Details
We value your opinion.
